Skip to Content

Join the 'Herpes Simplex, Mucocutaneous / Immunocompromised Host' group to help and get support from people like you.

Herpes Simplex, Mucocutaneous / Immunocompromised Host News

Genital Herpes Vaccine Shows Promise in Animal Trials

Posted 20 Jan 2017 by Drugs.com

THURSDAY, Jan. 19, 2017 – A new vaccine for genital herpes could be nearing human clinical trials, researchers say. The vaccine has proven effective in animals against herpes simplex virus 2, the sexually transmitted virus that causes genital herpes, according to a new report. The new "trivalent" vaccine targets three different parts of the virus, shutting down its ability to enter cells and to ...

Task Force: Routine Genital Herpes Screening Not Recommended

Posted 2 Aug 2016 by Drugs.com

TUESDAY, Aug. 2, 2016 – A U.S. federal task force is prepared to recommend that teens, adults and pregnant women not be routinely tested for genital herpes if they don't have signs of infection. About one in every six Americans between the ages of 14 and 49 has genital herpes, according to the U.S. Centers for Disease Control and Prevention. The disease, which is transmitted through vaginal, ...

New STD Report Finds Some Progress, High Costs for U.S.

Posted 23 Nov 2010 by Drugs.com

MONDAY, Nov. 22 – The approximately 19 million new sexually transmitted disease (STD) infections that occur each year in the United States cost the health care system about $16.4 billion annually, the U.S. Centers for Disease Control and Prevention said in its annual STD report released Monday. The data for 2009 shows a continued high burden of STDs but there are some signs of progress, ...

Ask a Question

Further Information

Related Condition Support Groups

Herpes Simplex

Related Drug Support Groups

Valtrex, acyclovir, valacyclovir, famciclovir, Famvir, foscarnet, Foscavir